A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist
Akinori Morita(Hiroshima University), Toshiya Inaba(Hiroshima University), Chihiro Yanagawa(Tokushima University), Shin Aoki(Tokyo University of Science), Atsushi Enomoto(University of Tokyo Hospital), Bing Wang(Huazhong Agricultural University), Shinya Ariyasu(Chiba Cancer Center), Tatsuro Teraoka(Tokyo University of Pharmacy and Life Sciences), Tetsuji Yamaguchi(Hiroshima University), Shohei Ujita(Tokushima University), Ippei Takahashi(Hiroshima University), Yoshio Hosoi(Hyogo Medical University), Yurie Nishi(Tokyo University of Pharmacy and Life Sciences), Akiko Sawa(Tokyo University of Pharmacy and Life Sciences), Yosuke Kawate(Tokushima University), Mitsuru Nenoi, Kaoru Tanaka(Kindai University), Keiji Tanimoto(Hiroshima University), Megumi Sasatani(Hiroshima University), Yasushi Nagata(Hiroshima University Hospital), Kenji Kamiya(Fukushima Medical University)
Cited by 19
Related Papers
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
|JAMA Oncology|2017|1k
Fusion of the Leucine Zipper Gene <i>HLF</i> to the <i>E2A</i> Gene in Human Acute B-Lineage Leukemia
|Science|1992|298